Cargando…
EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity
Adrenocortical carcinoma affects one in 5 million children each year. Since prognosis for children older than 4 years is limited, clinicians often choose aggressive treatment with etoposide, doxorubicin, cisplatin (EDP) and mitotane after resection. However, little is known about the impact of EDP-m...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016089/ https://www.ncbi.nlm.nih.gov/pubmed/35435506 http://dx.doi.org/10.1007/s12672-022-00486-1 |